Stay updated on MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Sign up to get notified when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.

Latest updates to the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedVersion updated from v3.5.3 to v3.5.4. This likely reflects minor fixes or clarifications in the page’s documentation, without changing substantive study details.SummaryDifference0.0%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site build or release update rather than a change to the clinical study record.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a minor version update with no changes to study content.SummaryDifference0.0%

- Check53 days agoChange DetectedAdded Squamous cell carcinoma of the head and neck as a listed condition and included the Genetic and Rare Diseases Information Center as a resources link.SummaryDifference0.1%

- Check68 days agoChange DetectedRevision tag updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.0%

- Check75 days agoChange DetectedAdded Revision: v3.4.3 and removed Revision: v3.4.2.SummaryDifference0.0%

Stay in the know with updates to MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MT-6402 in PD-L1-Expressing Solid Cancer Clinical Trial page.